Cronos Group

CRON65

Penny Stock

$2.23arrow_drop_down1.76%-$0.04

Penny Stock

CRON65

$2.23

arrow_drop_down1.76%-$0.04

Penny Stock

Performance History

Key Stats
Open	$2.30
Prev. Close	$2.27
EPS	-0.15
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$863.95M
PE Ratio	-

	LOW	HIGH
Day Range	2.23	2.33
52 Week Range	1.70	3.14

Ratios







EPS	-0.15

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Cronos Group (CRON)

Cronos Group Inc (CRON) is a leading cannabis company that operates in the global cannabis industry. The company is focused on building disruptive brands for consumers and is committed to creating a balanced portfolio of brands that have the potential to reshape industries. Cronos Group believes that cannabis has the potential to transform several industries including health and wellness, alcohol, and tobacco. The company's goal is to create products that offer consumers options and provide an experience that meets their diverse needs.

Cronos Group's stock price history has seen significant volatility over the years. The stock has experienced both highs and lows, reflecting the overall market sentiment towards the cannabis industry. It is important for investors to consider the long-term prospects of the company and the industry as a whole when evaluating Cronos Group's stock price. The company's quote provides real-time information on its stock price, allowing investors to stay updated on its performance.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO: Mr. Michael Ryan Gorenstein J.D.
Headquarters: Toronto
Employees: 447
Exchange: NASDAQ

Keep an eye on Cronos Group

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of Cronos Group (CRON)?

Cronos Group (CRON) has a market capitalization of $863.96M. The average daily trading volume is 932.59K, indicating the stock's liquidity and investor engagement.

help

Is Cronos Group (CRON) a profitable company?

Cronos Group (CRON) has a net income of -$71.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 7.87% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -54.08% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $88.84M, although specific revenue growth data is currently not available. The gross profit is $6.99M. Operating income is noted at -$81.38M. Furthermore, the EBITDA is -$61.51M.

help

What is Cronos Group 's (CRON) price per share?

The current price per share for Cronos Group (CRON) is $2.23. The stock has seen a price change of -$0.04 recently, indicating a -1.76% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Cronos Group (CRON)?

For Cronos Group (CRON), the 52-week high is $3.14, which is 40.81% from the current price. The 52-week low is $1.7, the current price is 31.18% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Cronos Group (CRON) a growth stock?

Cronos Group (CRON) has shown an average price growth of 0.41% over the past three years. It has received a score of 25 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Cronos Group as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Cronos Group (CRON) stock price performance year to date (YTD)?

As of the latest data, Cronos Group (CRON) has a year-to-date price change of 5.69%. Over the past month, the stock has experienced a price change of -7.47%. Over the last three months, the change has been -3.46%. Over the past six months, the figure is 0%. Looking at a longer horizon, the five-year price change stands at -79.65%.